Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Aratana Therapeutics (PETX)

Add to Watchlists
Create an Alert
14.09 +0.03  +0.21% NASDAQ Apr 24, 3:23PM BATS Real time Currency in USD
View Full Chart
PETX Price Chart
View All Performance Charts

PETX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Aratana Therapeutics is up N/A over the last year vs S&P 500 Total Return up 21.55%, WuXi PharmaTech up 100.4%, and Biocryst Pharmaceuticals up 372.8%.

Get Quote for

Portfolio Strategies Featuring PETX

Did Aratana Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PETX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: N/A
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Aratana Therapeutics Inc is a development-stage biopharmaceutical company. It is engaged in licensing, development and commercialization of prescription medicines for pets.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PETX 14.09 +0.03 +0.21% 330.07M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.